Sustainable TPE Tubing in Biopharma

After an “incredibly difficult time”, the life science industry in the UK is showing clear signs of renewed momentum as venture capital is edging upward and activity across the ecosystem is intensifying.

The Board of Directors has with immediate effect among its members elected Erik Gatenholm to serve as Board Chair of BICO Group AB, until a new Board Chair has been elected by the extraordinary shareholders’ meeting.

Johnson & Johnson has entered a strategic collaboration with Sail Biomedicines to advance in vivo CAR-T therapies for immune-mediated diseases.

FedEx has announced the launch of FedEx Life Sciences, a dedicated organization created to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials, and other critical healthcare shipments.

Researchers at the University of Turku have developed a new preclinical model that could help accelerate drug development for BAP1-deficient melanomas, a rare and highly aggressive form of melanoma that is resistant to current immunotherapies.

Medivir has received a Notice of Allowance from the US Patent and Trademark Office for its patent application covering the combination of fostroxacitabine bralpamide (fostrox) and lenvatinib in hepatocellular carcinoma and liver metastases.

Pharmability has received approval from the Swedish Medical Products Agency to start a Phase Ib clinical trial of its lead candidate TIR-C in atopic dermatitis, marking the company’s move from preclinical to clinical development.